A study in humans demonstrated that the mir-6779-3p was downregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention compared to those without recurrent events, with this differential expression remaining significant after false-discovery rate correction in a replication cohort [Onuoha et al. DOI:10.1111/cts.13307].